Cytomics as a new potential for drug discovery

Area of Science:

• Biomedical Sciences
• Computational Biology
• Genomics

Background:

• High-content screening (HCS) analyzes cellular and tissue samples at the single-cell level.
• Data-pattern analysis combined with HCS generates differential molecular profiles.
• These profiles are crucial for understanding patient-specific disease progression and treatment responses.

Purpose of the Study:

• To explore molecular pathways using systems biology for personalized medicine.
• To identify novel drug targets by reverse-engineering molecular profiles.
• To enable early detection of adverse drug reactions in stratified patient groups.

Main Methods:

• Utilizing high-content screening (image analysis or flow cytometry) on clinical samples.
• Applying data-pattern analysis for differential molecular profiling.
• Employing systems biology for molecular reverse-engineering of pathways.

Main Results:

• Generation of molecular profiles for personalized prediction of therapy-dependent disease progression.
• Identification of potential new drug targets through pathway exploration.
• Demonstration of cytomics' role in predictive and personalized medicine.

Conclusions:

• Single-cell analysis and systems biology advance personalized medicine.
• This integrated approach facilitates accurate disease progression prediction and drug target discovery.
• Cytomics offers a pathway for individualized treatments and early adverse drug reaction detection.